News
- Author:
- Sara Freeman
Publish date: May 19, 2015
Key clinical point: A risk-prediction model may help primary care physicians diagnose lupus earlier.
Major finding: Lupus patients consulted more...
News
- Author:
- Sara Freeman
Publish date: May 14, 2015
Key clinical point: Shortening HCV therapy to 6-8 weeks is possible, even in cirrhotic patients.
Major finding: SVR12 was achieved by 87%-94% of G...
News
- Author:
- Sara Freeman
Publish date: May 14, 2015
Key clinical point: Anti-CarP antibodies may provide additional prognostic information to current antibody tests in early inflammatory arthritis.
...
News
- Author:
- Sara Freeman
Publish date: May 13, 2015
Key clinical point: Patients with RA in clinical remission defined via clinical criteria alone may still have subclinical inflammation.
Major find...
News
- Author:
- Sara Freeman
Publish date: May 13, 2015
Key clinical point: The halo sign on ultrasound is a diagnostic and potentially prognostic marker, but its use is limited by the effect of early h...
News
- Author:
- Sara Freeman
Publish date: May 13, 2015
Key clinical point: Vitamin E was shown to improve nonalcoholic steatohepatitis (NASH) to an extent similar to those of pioglitazone, metformin, a...
News
- Author:
- Sara Freeman
Publish date: May 13, 2015
Key clinical point: Early data suggest that synovial tissue analysis may be a potential tool to guide anti-TNF therapy, although more data are nee...
News
- Author:
- Sara Freeman
Publish date: May 12, 2015
Key clinical point: Although the majority of patients benefited from rituximab, a significant proportion did not, highlighting the need to identif...
News
- Author:
- Sara Freeman
Publish date: May 11, 2015
Key clinical point: Patients with systemic lupus erythematosus can achieve complete remission for many years, but relapse can occur decades later,...
News
- Author:
- Sara Freeman
Publish date: May 10, 2015
Key clinical point: Efficacy diminishes when HCV treatment is delayed, particularly in patients who progress to advanced cirrhosis.
Major finding:...
News
- Author:
- Sara Freeman
Publish date: May 10, 2015
Key clinical point: Efficacy diminishes when HCV treatment is delayed, particularly in patients who progress to advanced cirrhosis.
Major finding:...
News
- Author:
- Sara Freeman
Publish date: May 9, 2015
Key clinical point: An all-oral antiviral regimen appears effective and safe for most patients with decompensated cirrhosis due to chronic HCV inf...
News
- Author:
- Sara Freeman
Publish date: May 6, 2015
Key clinical point: A high rate of hepatic focal lesions suggests that about 10% of patients per year may need a recall diagnosis procedure.
News
- Author:
- Sara Freeman
Publish date: May 5, 2015
Key clinical point: Chronic HCV infection was strongly linked to CV outcome and needs to be considered a CV risk factor.
Major finding: Adjusted o...
News
- Author:
- Sara Freeman
Publish date: May 5, 2015
Key clinical point: Chronic HCV infection was strongly linked to CV outcome and needs to be considered a CV risk factor.
Major finding: Adjusted o...
